Pharma ad deal challenged by FTC

IQVIA’s purchase of Propel Media could cause both horizontal and vertical harm in the market for digital healthcare advertising worldwide, the Federal Trade Commission has said, as it filed an administrative complaint to block the deal.

Unlock unlimited access to all Global Competition Review content